Skip to content
  • Saturday, 15 August 2026
  • 1:01 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Rethinking the Arrow of Time: New Research Challenges Assumptions Underlying the Boltzmann Brain Hypothesis
Neuroscience & Brain Research

Rethinking the Arrow of Time: New Research Challenges Assumptions Underlying the Boltzmann Brain Hypothesis

Rifan Muazin May 20, 2026 0

The nature of human memory, the progression of time, and the very foundation of cosmological history have been called into…

Read More
Neuroscience & Brain Research

New Research Challenges the Foundations of Time and Memory through the Lens of the Boltzmann Brain Hypothesis

Rifan Muazin May 11, 2026 0

A collaborative study led by Santa Fe Institute (SFI) Professor David Wolpert, SFI Fractal Faculty member Carlo Rovelli, and physicist…

Read More
Neuroscience & Brain Research

Entropy Memory and the Mirage of Time A Reevaluation of the Boltzmann Brain Hypothesis

Rifan Muazin May 4, 2026 0

The Santa Fe Institute has released a provocative new study that challenges the fundamental reliability of human memory and the…

Read More
Traumatic brain injury and Alzheimer’s disease, common neuroinflammatory pathologies and therapeutic potentialScience News: Empowering Public Understanding of Science Since 1921A Rare Lunar Impact Creates a Crater the Size of Two Football FieldsScience News: A Century of Illuminating the World of Science
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ